Literature DB >> 16934166

Clinical approach to the weak patient in the intensive care unit.

Upinder K Dhand1.   

Abstract

Motor weakness in a patient in the intensive care unit (ICU) may be related to (1) pre-existing neuromuscular disorder that leads to ICU admission, (2) new-onset or previously undiagnosed neurological disorder, or (3) complications of non-neuromuscular critical illness. Neuromuscular syndromes related to ICU treatment consist of critical illness polyneuropathy, critical illness myopathy, and prolonged neuromuscular blockade, and are now recognized as a frequent cause of newly acquired weakness in ICU patients. Clinical features include quadriparesis, muscle wasting, and difficulty weaning from the ventilator. Evaluation of these patients is based on knowledge of clinical setting and predisposing factors, focused neurological examination, detailed electrophysiological investigation, serum creatine kinase level, other laboratory studies as needed, and histological examination of muscle biopsy. If a central nervous system (brain or spinal cord) lesion is suspected, neuroimaging studies are required. In addition to conventional nerve conduction and needle electromyography, phrenic nerve conduction, diaphragm electromyography, blink reflex, and (recently) the technique of direct muscle stimulation have been employed. Critical illness polyneuropathy is an axonal motor and sensory neuropathy that often follows sepsis and multiorgan failure. Risk factors for critical illness myopathy are corticosteroids and neuromuscular blocking drugs, acute respiratory illness, and organ transplant. Three subtypes (acute necrotizing myopathy, thick myosin filament loss myopathy, and type II fiber atrophy) are recognized. Major differential diagnoses of critical illness related paralysis are incidental Guillain-Barré syndrome and unmasked myasthenia gravis. Rarely, atypical presentation of amyotrophic lateral sclerosis, polymyositis or other myopathies, and precipitation of porphyria or rhabdomyolysis due to drugs used in the ICU have been described. Recently a poliomyelitis-like flaccid paralysis due to West Nile virus infection was reported. A subgroup of patients with myasthenia gravis with muscle-specific tyrosine kinase antibody is noted to present as respiratory crisis. Muscle biopsy in ICU paralysis syndromes may be helpful in arriving at a specific diagnosis or to classify the type of critical illness myopathy. Nerve biopsy is only rarely indicated.

Entities:  

Mesh:

Year:  2006        PMID: 16934166

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  16 in total

Review 1.  Critical illness polyneuropathy and myopathy in the intensive care unit.

Authors:  Wolfgang Zink; Rainer Kollmar; Stefan Schwab
Journal:  Nat Rev Neurol       Date:  2009-07       Impact factor: 42.937

Review 2.  Intensive care unit-related generalized neuromuscular weakness due to critical illness polyneuropathy/myopathy in critically ill patients.

Authors:  Efstratios Apostolakis; Nikolaos A Papakonstantinou; Nikolaos G Baikoussis; George Papadopoulos
Journal:  J Anesth       Date:  2014-07-01       Impact factor: 2.078

Review 3.  Implications of glucocorticoid therapy in idiopathic inflammatory myopathies.

Authors:  Beatriz Y Hanaoka; Charlotte A Peterson; Craig Horbinski; Leslie J Crofford
Journal:  Nat Rev Rheumatol       Date:  2012-06-12       Impact factor: 20.543

4.  Early Physical Rehabilitation in the ICU: A Review for the Neurohospitalist.

Authors:  Pedro A Mendez-Tellez; Rasha Nusr; Dorianne Feldman; Dale M Needham
Journal:  Neurohospitalist       Date:  2012-07

5.  Sepsis: a review for the neurohospitalist.

Authors:  Lioudmila V Karnatovskaia; Emir Festic
Journal:  Neurohospitalist       Date:  2012-10

6.  Phase I/II trial of adeno-associated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomes.

Authors:  Barbara K Smith; Shelley W Collins; Thomas J Conlon; Cathryn S Mah; Lee Ann Lawson; Anatole D Martin; David D Fuller; Brian D Cleaver; Nathalie Clément; Dawn Phillips; Saleem Islam; Nicole Dobjia; Barry J Byrne
Journal:  Hum Gene Ther       Date:  2013-06       Impact factor: 5.695

Review 7.  Antimalarial myopathy in a systemic lupus erythematosus patient with quadriparesis and seizures: a case-based review.

Authors:  Kashif Jafri; Hengameh Zahed; Katherine D Wysham; Sarah Patterson; Amber L Nolan; Matthew D Bucknor; R Krishna Chaganti
Journal:  Clin Rheumatol       Date:  2017-02-24       Impact factor: 3.650

8.  Muscle wasting and the temporal gene expression pattern in a novel rat intensive care unit model.

Authors:  Monica Llano-Diez; Ann-Marie Gustafson; Carl Olsson; Hanna Goransson; Lars Larsson
Journal:  BMC Genomics       Date:  2011-12-13       Impact factor: 3.969

Review 9.  Clinical review: the ABC of weaning failure--a structured approach.

Authors:  Leo M Heunks; Johannes G van der Hoeven
Journal:  Crit Care       Date:  2010-12-08       Impact factor: 9.097

10.  Mechanisms underlying ICU muscle wasting and effects of passive mechanical loading.

Authors:  Monica Llano-Diez; Guillaume Renaud; Magnus Andersson; Humberto Gonzales Marrero; Nicola Cacciani; Henrik Engquist; Rebeca Corpeño; Konstantin Artemenko; Jonas Bergquist; Lars Larsson
Journal:  Crit Care       Date:  2012-10-26       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.